TED (Tenders Electronic Daily), notices since 2026-09-15

Spain – Various medicinal products – 23/S/25/SU/DG/A/AM29 - Suministros de medicamentos no exclusivos de uso humano tipo I incluidos en el grupo terapéutico J de la clasificación ATC con destino al Servicio Canario de la Salud

Title: Spain – Various medicinal products – 23/S/25/SU/DG/A/AM29 - Suministros de medicamentos no exclusivos de uso humano tipo I incluidos en el grupo terapéutico J de la clasificación ATC con destino al Servicio Canario de la Salud
Notice type: can-standard
Buyer: Dirección General de Recursos Económicos del Servicio Canario de la Salud
Buyer country: ESP
Published: 2026-09-24+02:00
Deadline by lot: not on file
CPV: 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000, 33690000
Nature: supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies, supplies
Procedure: open
Estimated value: not on file
Currency: not on file
Place of performance: ES703, ES704, ES705, ES706, ES707, ES708, ES709, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ES703, ES704, ES705, ES706, ES707, ES708, ES709, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP, ESP
Winner: Sandoz Farmaceutica; LABORATORIOS NORMON, S.A.; PFIZERSLU; LABORATORIOS LORIEN S.L.U.; SUN PHARMA LABORATORIOS, SLU; LAPHYSAN, S.A.U.; FRESENIUS KABI ESPAÑA, S.A.; ACCORD HEALTHCARE, SLU; VIVANTA GENERICS S.R.O. SUCURSAL EN ESPAÑA; GLENMARK FARMACÉUTICA, S.L.U.; TARBIS FARMA S.L.; Reddy Pharma Iberia SAU; MACLEODS PHARMA ESPAÑA S.L.U
Awarded value: 0.79, 1.54, 1.19, 0.57, 30, 0.32, 19.45, 27.45, 0.46, 1.63, 2.71, 0.9, 1.52, 0.48, 0.85, 0.76, 0.08, 3.3, 0.61, 1.69, 1.02, 1.19, 163.96, 1.22, 1.05, 2.18, 1.15, 0.3, 7, 7.1, 2.08, 0.18
TED publication number: 658749-2026

Where this comes from

Register: TED (Tenders Electronic Daily), notices since 2026-09-15
Publisher: Publications Office of the European Union
File: pages.json
sha256: cef5c1d7d0fa
Size: 406905474 bytes
Published: date not stated
Read: 2026-10-04T18:13:29.076Z
Source file: Source file retained · verify
Refresh due: 2026-10-05

TED data may be reused under the Commission's reuse policy (Decision 2011/833/EU) per the TED legal notice; the API is open at developer.ted.europa.eu.

Cite as

TED (Tenders Electronic Daily), notices since 2026-09-15 (Publications Office of the European Union), pages.json, sha256 cef5c1d7d0fa, published date not stated

Search this register